Joseph R. Hyde III
Description
Mr. Hyde, in conjunction with Dr. Wills’ appointment as our Executive Chairman effective March 2, 2015, was appointed as the Board’s Lead Di...
Investor Profile
Joseph R. Hyde III has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series E rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biopharma, Biotechnology, Health Care.
Stage Focus
- Series E (100%)
Country Focus
- United States (100%)
Industry Focus
- Biopharma
- Biotechnology
- Health Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
